Alcon Japan, Kyowa Hakko Kogyo to Join Hands in Sales and Promotion of Olopatadine Hydrochloride Ophthalmic Solution.Tokyo, Japan, June 29, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Alcon Japan and Kyowa Hakko Kogyo have signed an agreement for the olopatadine hydrochloride hydrochloride /hy·dro·chlo·ride/ (-klor´id) a salt of hydrochloric acid. hy·dro·chlo·ride n. A compound resulting from the reaction of hydrochloric acid with an organic base. ophthalmic solution ophthalmic solution n. A sterile solution that is free from foreign particles and is compounded and dispensed for eyedrops. , a prescription eye drop for the treatment of allergy allergy, hypersensitive reaction of the body tissues of certain individuals to certain substances that, in similar amounts and circumstances, are innocuous to other persons. Allergens, or allergy-causing substances, can be airborne substances (e.g. . Under the agreement terms, the two companies will jointly sell and promote the agent in Japan. The ophthalmic solution, for which Alcon Japan filed a new drug application in June 2003, is currently available in 83 countries worldwide. In the US, it is marketed under the trade name of Patanol. Alcon Japan expects to obtain approval and begin distributing the agent with the year. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion